Professionally designed and constructed, the Momcozy nasal aspirator offers improved versatility and comfort when it comes to ...
The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.
Approval based on WAYPOINT Phase III results demonstrating reduced nasal polyp severity and nasal congestion, near-elimination of the need for surgery and significantly reduced systematic ...
Diwali, with AQI at 358. We got in touch with experts warn smog can trigger sinus problems, migraines, and long-term lung ...
The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus ...
Investing.com -- AstraZeneca and Amgen have received European Union approval for Tezspire as an add-on therapy for adults ...
Amgen and AstraZeneca’s Tezspire (tezepelumab-ekko) gains FDA approval as an add-on maintenance therapy for patients aged 12 and older with inadequately controlled chronic rhinosinusitis with nasal ...
The FDA approved tezepelumab-ekko (TEZSPIRE; AstraZeneca/Amgen) on Friday as an add-on maintenance treatment in patients aged ...
Sleep is a critical for one's wellbeing, however, according to the National Institutes of Health, 1 in 3 U.S. adults don't ...
Waking up with a stuffy nose is common and usually caused by allergies, nasal inflammation, post-nasal drip, sleep position or structural issues like a deviated septum.
At the LifeBridge Health ENT Sinus & Allergy Center, Dr. Alpen Patel helps patients get to the root of disrupted sleep. With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback